The Food and Drug Administration (FDA) recently approved the nasal spray Spravato for the treatment of major depression in ...

A Mail on Sunday investigation has discovered firms are claiming cannabis can treat a range of serious conditions/ ...

Spravato, a newly FDA-approved nasal spray, offers hope for individuals with treatment-resistant depression, a condition ...

A woman died after taking a large quantity of medication prescribed for the severe migraines she suffered. Katie Jones, 20, who her family said was much loved, had no plans to end her life, although ...

Here's what MDs want you to know about Spravato, the latest FDA-approved standalone nasal spray for depression.

A woman who suffered from severe migraines died after taking an overdose of a drug prescribed to treat them. Much-loved Katie ...

Johnson & Johnson has announced the FDA’s approval of a first-of-its-kind, esketamine nasal spray called Spravato for the ...

Johnson & Johnson's Spravato nasal spray has been FDA-approved as a stand-alone therapy for adults with treatment-resistant ...

The FDA says esketamine, an antidepressant derived from the anesthetic and party drug ketamine, can now be prescribed on its ...

The U.S. Food and Drug Administration expanded approval for Johnson & Johnson's nasal spray, Spravato, to allow it to be used ...